Imperial College London

Professor Josip Car

Faculty of MedicineSchool of Public Health

Visiting Professor
 
 
 
//

Contact

 

+44 (0)20 7594 0799josip.car Website

 
 
//

Location

 

326Reynolds BuildingCharing Cross Campus

//

Summary

 

Publications

Publication Type
Year
to

540 results found

Kendrick PJ, Reitsma MB, Abbasi-Kangevari M, Abdoli A, Abdollahi M, Abedi A, Abhilash ES, Aboyans V, Adebayo OM, Advani SM, Ahinkorah BO, Ahmad S, Ahmadi K, Ahmed H, Aji B, Akalu Y, Akunna CJ, Alahdab F, Al-Aly Z, Alanezi FM, Alanzi TM, Alhabib KF, Ali T, Alif SM, Alipour V, Aljunid SM, Alomari MA, Amin TT, Amini S, Amu H, Ancuceanu R, Anderson JA, Andrei CL, Andrei T, Ansari-Moghaddam A, Antony B, Anvari D, Arabloo J, Arian ND, Arora M, Artanti KD, Asmare WN, Atnafu DD, Ausloos M, Awan AT, Ayano G, Aynalem GL, Azari S, B DB, Badiye AD, Baig AA, Banach M, Banerjee SK, Barker-Collo SL, Bärnighausen TW, Barqawi HJ, Basu S, Bayati M, Bazargan-Hejazi S, Bekuma TT, Bennett DA, Bensenor IM, Benzian H, Benziger CP, Berman AE, Bhagavathula AS, Bhala N, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bibi S, Bijani A, Biondi A, Braithwaite D, Brenner H, Brunoni AR, Burkart K, Burugina Nagaraja S, Butt ZA, Caetano dos Santos FL, Car J, Carreras G, Castaldelli-Maia JM, Cattaruzza MSS, Chang J-C, Chaturvedi P, Chen S, Chido-Amajuoyi OG, Chu D-T, Chung S-C, Ciobanu LG, Costa VM, Couto RAS, Dagnew B, Dai X, Damasceno AAM, Damiani G, Dandona L, Dandona R, Daneshpajouhnejad P, Darega Gela J, Derbew Molla M, Desta AA, Dharmaratne SD, Dhimal M, Eagan AW, Ebrahimi Kalan M, Edvardsson K, Effiong A, El Tantawi M, Elbarazi I, Esmaeilnejad S, Fadhil I, Faraon EJA, Farwati M, Farzadfar F, Fazlzadeh M, Feigin VL, Feldman R, Filip I, Filippidis F, Fischer F, Flor LS, Foigt NA, Folayan MO, Foroutan M, Gad MM, Gallus S, Geberemariyam BS, Gebregiorgis BG, Getacher L, Getachew Obsa A, Ghafourifard M, Ghanei Gheshlagh R, Ghashghaee A, Ghith N, Gil GF, Gill PS, Ginawi IA, Goharinezhad S, Golechha M, Gopalani SV, Gorini G, Grivna M, Guha A, Guimarães RA, Guo Y, Gupta RD, Gupta R, Gupta T, Gupta V, Hafezi-Nejad N, Haider MR, Hamadeh RR, Hankey GJ, Hargono A, Hay SI, Heidari G, Herteliu C, Hezam K, Hird TR, Holla R, Hosseinzadeh M, Hostiuc M, Hostiuc S, Househ M, Hsiao T, Huang J, Ibeneme CU, Ibitoye SE, Ilet al., 2021, Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019, The Lancet Public Health, Vol: 6, Pages: e482-e499, ISSN: 2468-2667

BackgroundChewing tobacco and other types of smokeless tobacco use have had less attention from the global health community than smoked tobacco use. However, the practice is popular in many parts of the world and has been linked to several adverse health outcomes. Understanding trends in prevalence with age, over time, and by location and sex is important for policy setting and in relation to monitoring and assessing commitment to the WHO Framework Convention on Tobacco Control.MethodsWe estimated prevalence of chewing tobacco use as part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 using a modelling strategy that used information on multiple types of smokeless tobacco products. We generated a time series of prevalence of chewing tobacco use among individuals aged 15 years and older from 1990 to 2019 in 204 countries and territories, including age-sex specific estimates. We also compared these trends to those of smoked tobacco over the same time period.FindingsIn 2019, 273·9 million (95% uncertainty interval 258·5 to 290·9) people aged 15 years and older used chewing tobacco, and the global age-standardised prevalence of chewing tobacco use was 4·72% (4·46 to 5·01). 228·2 million (213·6 to 244·7; 83·29% [82·15 to 84·42]) chewing tobacco users lived in the south Asia region. Prevalence among young people aged 15–19 years was over 10% in seven locations in 2019. Although global age-standardised prevalence of smoking tobacco use decreased significantly between 1990 and 2019 (annualised rate of change: –1·21% [–1·26 to –1·16]), similar progress was not observed for chewing tobacco (0·46% [0·13 to 0·79]). Among the 12 highest prevalence countries (Bangladesh, Bhutan, Cambodia, India, Madagascar, Marshall Islands, Myanmar, Nepal, Pakistan, Palau, Sri Lanka, and Yemen), only Yemen had a significant

Journal article

Udeh-Momoh CT, Watermeyer T, Price G, de Jager Loots CA, Reglinska-Matveyev N, Ropacki M, Ketter N, Fogle M, Raghavan N, Arrighi M, Brashear R, Di J, Baker S, Giannakopoulou P, Robb C, Bassil D, Cohn M, McLellan-Young H, Crispin J, Lakey K, Lisa C, Chowdary Seemulamoodi Y, Kafetsouli D, Perera D, Car J, Majeed A, Ward H, Ritchie K, Perneczky R, Kivipelto M, Scott D, Bracoud L, Saad Z, Novak G, Ritchie CW, Middleton Let al., 2021, Protocol of the cognitive health in ageing register: investigational, observational and trial studies in dementia research (CHARIOT): prospective readiness cOhort (PRO) SubStudy., BMJ Open, Vol: 11, Pages: 1-12, ISSN: 2044-6055

INTRODUCTION: The Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudy (CPSS), sponsored by Janssen Pharmaceutical Research & Development LLC, is an Alzheimer's disease (AD) biomarker enriched observational study that began 3 July 2015 CPSS aims to identify and validate determinants of AD, alongside cognitive, functional and biological changes in older adults with or without detectable evidence of AD pathology at baseline. METHODS AND ANALYSIS: CPSS is a dual-site longitudinal cohort (3.5 years) assessed quarterly. Cognitively normal participants (60-85 years) were recruited across Greater London and Edinburgh. Participants are classified as high, medium (amnestic or non-amnestic) or low risk for developing mild cognitive impairment-Alzheimer's disease based on their Repeatable Battery for the Assessment of Neuropsychological Status performance at screening. Additional AD-related assessments include: a novel cognitive composite, the Global Preclinical Alzheimer's Cognitive Composite, brain MRI and positron emission tomography and cerebrospinal fluid analysis. Lifestyle, other cognitive and functional data, as well as biosamples (blood, urine, and saliva) are collected. Primarily, study analyses will evaluate longitudinal change in cognitive and functional outcomes. Annual interim analyses for descriptive data occur throughout the course of the study, although inferential statistics are conducted as required. ETHICS AND DISSEMINATION: CPSS received ethical approvals from the London-Central Research Ethics Committee (15/LO/0711) and the Administration of Radioactive Substances Advisory Committee (RPC 630/3764/33110) The study is at the forefront of global AD prevention efforts, with frequent and robust sampling of the well-characterised cohort, allowing for detection of incipient pathophysiological, cognitive and functional changes that could inform therape

Journal article

Reitsma MB, Kendrick PJ, Ababneh E, Abbafati C, Abbasi-Kangevari M, Abdoli A, Abedi A, Abhilash ES, Abila DB, Aboyans V, Abu-Rmeileh NME, Adebayo OM, Advani SM, Aghaali M, Ahinkorah BO, Ahmad S, Ahmadi K, Ahmed H, Aji B, Akunna CJ, Al-Aly Z, Alanzi TM, Alhabib KF, Ali L, Alif SM, Alipour V, Aljunid SM, Alla F, Allebeck P, Alvis-Guzman N, Amin TT, Amini S, Amu H, Amul GGH, Ancuceanu R, Anderson JA, Ansari-Moghaddam A, Antonio CAT, Antony B, Anvari D, Arabloo J, Arian ND, Arora M, Asaad M, Ausloos M, Awan AT, Ayano G, Aynalem GL, Azari S, B DB, Badiye AD, Baig AA, Bakhshaei MH, Banach M, Banik PC, Barker-Collo SL, Bärnighausen TW, Barqawi HJ, Basu S, Bayati M, Bazargan-Hejazi S, Behzadifar M, Bekuma TT, Bennett DA, Bensenor IM, Berfield KSS, Bhagavathula AS, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bibi S, Bijani A, Bintoro BS, Biondi A, Birara S, Braithwaite D, Brenner H, Brunoni AR, Burkart K, Butt ZA, Caetano dos Santos FL, Cámera LA, Car J, Cárdenas R, Carreras G, Carrero JJ, Castaldelli-Maia JM, Cattaruzza MSS, Chang J-C, Chen S, Chu D-T, Chung S-C, Cirillo M, Costa VM, Couto RAS, Dadras O, Dai X, Damasceno AAM, Damiani G, Dandona L, Dandona R, Daneshpajouhnejad P, Darega Gela J, Davletov K, Derbew Molla M, Dessie GA, Desta AA, Dharmaratne SD, Dianatinasab M, Diaz D, Do HT, Douiri A, Duncan BB, Duraes AR, Eagan AW, Ebrahimi Kalan M, Edvardsson K, Elbarazi I, El Tantawi M, Esmaeilnejad S, Fadhil I, Faraon EJA, Farinha CSES, Farwati M, Farzadfar F, Fazlzadeh M, Feigin VL, Feldman R, Fernandez Prendes C, Ferrara P, Filip I, Filippidis F, Fischer F, Flor LS, Foigt NA, Folayan MO, Foroutan M, Gad MM, Gaidhane AM, Gallus S, Geberemariyam BS, Ghafourifard M, Ghajar A, Ghashghaee A, Giampaoli S, Gill PS, Glozah FN, Gnedovskaya EV, Golechha M, Gopalani SV, Gorini G, Goudarzi H, Goulart AC, Greaves F, Guha A, Guo Y, Gupta B, Gupta RD, Gupta R, Gupta T, Gupta V, Hafezi-Nejad N, Haider MR, Hamadeh RR, Hankey GJ, Hargono A, Hartono RK, Hassankhani H, Hay SI, Heidari G, Hertelet al., 2021, Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019, The Lancet, Vol: 397, Pages: 2337-2360, ISSN: 0140-6736

BackgroundEnding the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally.MethodsWe estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global Burden of Diseases, Injuries, and Risk Factors Study. We modelled multiple smoking-related indicators from 3625 nationally representative surveys. We completed systematic reviews and did Bayesian meta-regressions for 36 causally linked health outcomes to estimate non-linear dose-response risk curves for current and former smokers. We used a direct estimation approach to estimate attributable burden, providing more comprehensive estimates of the health effects of smoking than previously available.FindingsGlobally in 2019, 1·14 billion (95% uncertainty interval 1·13–1·16) individuals were current smokers, who consumed 7·41 trillion (7·11–7·74) cigarette-equivalents of tobacco in 2019. Although prevalence of smoking had decreased significantly since 1990 among both males (27·5% [26·5–28·5] reduction) and females (37·7% [35·4–39·9] reduction) aged 15 years and older, population growth has led to a significant increase in the total number of smokers from 0·99 billion (0·98–1·00) in 1990. Globally in 2019, smoking tobacco use accounted for 7·69 million (7·16–8·20) deaths and 200 million (185–214) disability-adjusted life-years, and was the leading risk factor for death among males (20·2% [19·3–21·1] of male deaths). 6·68 million [86·9%] of 7·69 million deaths attributable to smoking tobacco use were among current smokers.Int

Journal article

Lall P, Dutta O, Tan WS, Patinadan PV, Kang NQY, Low CK, Car J, Ho AHYet al., 2021, "I decide myself"- A qualitative exploration of end of life decision making processes of patients and caregivers through Advance Care Planning, PLOS ONE, Vol: 16, ISSN: 1932-6203

Journal article

Lo ZJ, Surendra NK, Saxena A, Car Jet al., 2021, Clinical and economic burden of diabetic foot ulcers: A 5-year longitudinal multi-ethnic cohort study from the tropics, INTERNATIONAL WOUND JOURNAL, Vol: 18, Pages: 375-386, ISSN: 1742-4801

Journal article

Fadahunsi P, O'Connor S, Akinlua J, Wark P, Gallagher J, Caroll C, Car J, Majeed A, O'Donoghue Jet al., 2021, Information quality frameworks for digital health technologies: systematic review, Journal of Medical Internet Research, Vol: 23, ISSN: 1438-8871

Background: Digital health technologies (DHTs) generate a large volume of information used in health care for administrative, educational, research, and clinical purposes. The clinical use of digital information for diagnostic, therapeutic, and prognostic purposes has multiple patient safety problems, some of which result from poor information quality (IQ).Objective: This systematic review aims to synthesize an IQ framework that could be used to evaluate the extent to which digital health information is fit for clinical purposes.Methods: The review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines. We searched Embase, MEDLINE, PubMed, CINAHL, Maternity and Infant Care, PsycINFO, Global Health, ProQuest Dissertations and Theses Global, Scopus, and HMIC (the Health Management Information Consortium) from inception until October 2019. Multidimensional IQ frameworks for assessing DHTs used in the clinical context by health care professionals were included. A thematic synthesis approach was used to synthesize the Clinical Information Quality (CLIQ) framework for digital health.Results: We identified 10 existing IQ frameworks from which we developed the CLIQ framework for digital health with 13 unique dimensions: accessibility, completeness, portability, security, timeliness, accuracy, interpretability, plausibility, provenance, relevance, conformance, consistency, and maintainability, which were categorized into 3 meaningful categories: availability, informativeness, and usability.Conclusions: This systematic review highlights the importance of the IQ of DHTs and its relevance to patient safety. The CLIQ framework for digital health will be useful in evaluating and conceptualizing IQ issues associated with digital health, thus forestalling potential patient safety problems.Trial Registration: PROSPERO International Prospective Register of Systematic Reviews CRD42018097142; https://www.crd.york.ac.uk/pros

Journal article

Nazeha N, Sathish T, Soljak M, Dunleavy G, Visvalingam N, Divakar U, Bajpai RC, Soh CK, Christopoulos G, Car Jet al., 2021, A Comparative Study of International and Asian Criteria for Overweight or Obesity at Workplaces in Singapore, ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, Vol: 33, Pages: 404-410, ISSN: 1010-5395

Journal article

Martinengo L, Stona A-C, Tudor Car L, Lee J, Griva K, Car Jet al., 2021, Education on Depression in Mental Health Apps: Systematic Assessment of Characteristics and Adherence to Evidence-Based Guidelines (Preprint)

<sec> <title>BACKGROUND</title> <p>Suboptimal understanding of depression and mental health disorders by the general population is an important contributor to the wide treatment gap in depression. Mental health literacy encompasses knowledge and beliefs about mental disorders and supports their recognition, management, and prevention. Besides knowledge improvement, psychoeducational interventions reduce symptoms of depression, enhance help-seeking behavior, and decrease stigma. Mental health apps often offer educational content, but the trustworthiness of the included information is unclear.</p> </sec> <sec> <title>OBJECTIVE</title> <p>The aim of this study is to systematically evaluate adherence to clinical guidelines on depression of the information offered by mental health apps available in major commercial app stores.</p> </sec> <sec> <title>METHODS</title> <p>A systematic assessment of the educational content regarding depression in the apps available in the Apple App Store and Google Play was conducted in July 2020. A systematic search for apps published or updated since January 2019 was performed using 42matters. Apps meeting the inclusion criteria were downloaded and assessed using two smartphones: an iPhone 7 (iOS version 14.0.1) and a Sony XPERIA XZs (Android version 8.0.0). The 156-question assessment checklist comprised general characteristics of apps, appraisal of 38 educational topics and their adherence to evidence-based clinical guidelines, as well as technical aspects and quality assurance. The results were tabulated and reported as a narrative review, using descriptive statistics.</p> </sec>

Journal article

Meinert E, Eerens J, Banks C, Maloney S, Rivers G, Ilic D, Walsh K, Majeed A, Car Jet al., 2021, Exploring the Cost of eLearning in Health Professions Education: Scoping Review, JMIR MEDICAL EDUCATION, Vol: 7, ISSN: 2369-3762

Journal article

Surendran S, De Foo C, Tam CH, Ho EQY, Matchar DB, Car J, Koh GCHet al., 2021, The Missed Opportunity of Patient-Centered Medical Homes to Thrive in an Asian Context, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, Vol: 18

Journal article

Ho AHY, Lall P, Tan WS, Patinadan PV, Wong LH, Dutta O, Pang WS, Low CK, Car Jet al., 2021, Sustainable implementation of advance care planning in Asia: An interpretive-systemic framework for national development, PALLIATIVE & SUPPORTIVE CARE, Vol: 19, Pages: 82-92, ISSN: 1478-9515

Journal article

Martinengo L, Stona A-C, Griva K, Dazzan P, Pariante CM, von Wangenheim F, Car Jet al., 2021, Self-guided Cognitive Behavioral Therapy Apps for Depression: Systematic Assessment of Features, Functionality, and Congruence With Evidence (Preprint)

<sec> <title>BACKGROUND</title> <p>Mental health disorders affect 1 in 10 people globally, of whom approximately 300 million are affected by depression. At least half of the people affected by depression remain untreated. Although cognitive behavioral therapy (CBT) is an effective treatment, access to mental health specialists, habitually challenging, has worsened because of the COVID-19 pandemic. Internet-based CBT is an effective and feasible strategy to increase access to treatment for people with depression. Mental health apps may further assist in facilitating self-management for people affected by depression; however, accessing the correct app may be cumbersome given the large number and wide variety of apps offered by public app marketplaces.</p> </sec> <sec> <title>OBJECTIVE</title> <p>This study aims to systematically assess the features, functionality, data security, and congruence with evidence of self-guided CBT-based apps targeting users affected by depression that are available in major app stores.</p> </sec> <sec> <title>METHODS</title> <p>We conducted a systematic assessment of self-guided CBT-based apps available in Google Play and the Apple App Store. Apps launched or updated since August 2018 were identified through a systematic search in the 42matters database using CBT-related terms. Apps meeting the inclusion criteria were downloaded and assessed using a Samsung Galaxy J7 Pro (Android 9) and iPhone 7 (iOS 13.3.1). Apps were appraised using a 182-question checklist developed by the research team, assessing their general characteristics, technical aspects and quality assurance, and CBT-related features, including 6 evidence-based CBT tech

Journal article

Jimenez G, Matchar D, Koh CHG, van der Kleij R, Chavannes NH, Car Jet al., 2021, The Role of Health Technologies in Multicomponent Primary Care Interventions: Systematic Review, JOURNAL OF MEDICAL INTERNET RESEARCH, Vol: 23, ISSN: 1438-8871

Journal article

Udeh-Momoh CT, Watermeyer T, Sindi S, Giannakopoulou P, Robb CE, Ahmadi-Abhari S, Zheng B, Waheed A, McKeand J, Salman D, Beaney T, de Jager-Loots C, Price G, Atchison C, Car J, Majeed A, McGregor AH, Kivipelto M, Ward H, Middleton Let al., 2021, Associations of Health, Lifestyle and Psycho-Social Factors With Sleep Quality During the Early Phase of the COVID-19 Pandemic: A Focus on UK Older Adults Deemed Clinically Extremely Vulnerable, SSRN Electronic Journal

Journal article

Meinert E, Eerens J, Banks C, Maloney S, Rivers G, Ilic D, Walsh K, Majeed A, Car Jet al., 2021, Exploring the cost of eLearning within the field of health professions education: Scoping review, JMIR Medical Education, Vol: 7, ISSN: 2369-3762

Background:Existing research on the costs associated with the design and deployment of eLearning in health professions education is limited. The relative costs of these learning platforms to those of face-to-face learning are also not well understood. The lack of predefined costing models used for eLearning cost data capture has made it difficult to complete cost evaluation.Objective:The key aim of this scoping review was to explore the state of evidence concerning cost capture within eLearning in health professions education. The review explores the available data to define cost calculations related to eLearning.Methods:The scoping review was performed using a search strategy with Medical Subject Heading terms and related keywords centered on eLearning and cost calculation with a population scope of health professionals in all countries. The search was limited to articles published in English. No restriction was placed on literature publication date.Results:In total, 7344 articles were returned from the original search of the literature. Of these, 232 were relevant to associated keywords or abstract references following screening. Full-text review resulted in 168 studies being excluded. Of these, 61 studies were excluded because they were unrelated to eLearning and focused on general education. In addition, 103 studies were excluded because of lack of detailed information regarding costs; these studies referred to cost in ways either indicating cost favorability or unfavorability, but without data to support findings. Finally, 4 studies were excluded because of limited cost data that were insufficient for analysis. In total, 42 studies provided data and analysis of the impact of cost and value in health professions education. The most common data source was total cost of training (n=29). Other sources included cost per learner, referring to the cost for individual students (n=13). The population most frequently cited was medical students (n=15), although 12 article

Journal article

Jimenez G, Matchar D, Koh GC-H, Car Jet al., 2021, Multicomponent interventions for enhancing primary care: a systematic review, BRITISH JOURNAL OF GENERAL PRACTICE, Vol: 71, Pages: E10-E21, ISSN: 0960-1643

Journal article

De Foo C, Surendran S, Tam CH, Ho E, Matchar DB, Car J, Koh GCHet al., 2021, Perceived facilitators and barriers to chronic disease management in primary care networks of Singapore: a qualitative study, BMJ OPEN, Vol: 11, ISSN: 2044-6055

Journal article

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V, GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Groupet al., 2020, Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study., Journal of the American College of Cardiology, Vol: 76, Pages: 2982-3021, ISSN: 0735-1097

Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consistent estimates of population health over time, used all available population-level data sources on incidence, prevalence, case fatality, mortality, and health risks to produce estimates for 204 countries and territories from 1990 to 2019. Prevalent cases of total CVD nearly doubled from 271 million (95% uncertainty interval [UI]: 257 to 285 million) in 1990 to 523 million (95% UI: 497 to 550 million) in 2019, and the number of CVD deaths steadily increased from 12.1 million (95% UI:11.4 to 12.6 million) in 1990, reaching 18.6 million (95% UI: 17.1 to 19.7 million) in 2019. The global trends for disability-adjusted life years (DALYs) and years of life lost also increased significantly, and years lived with disability doubled from 17.7 million (95% UI: 12.9 to 22.5 million) to 34.4 million (95% UI:24.9 to 43.6 million) over that period. The total number of DALYs due to IHD has risen steadily since 1990, reaching 182 million (95% UI: 170 to 194 million) DALYs, 9.14 million (95% UI: 8.40 to 9.74 million) deaths in the year 2019, and 197 million (95% UI: 178 to 220 million) prevalent cases of IHD in 2019. The total number of DALYs due to stroke has risen steadily since 1990, reaching 143 million (95% UI: 133 to 153 million) DALYs, 6.55 million (95% UI: 6.00 to 7.02 million) deaths in the year 2019, and 101 million (95% UI: 93.2 to 111 million) prevalent cases of stroke in 2019. Cardiovascular diseases remain the leading cause of disease burden in the world. CVD burden continues its decades-long rise for almost al

Journal article

Surendra NK, Lo ZJ, Saxena A, Car Jet al., 2020, CLINICAL AND ECONOMIC BURDEN OF DIABETIC FOOT ULCERS: A 5-YEAR LONGITUDINAL INSTITUTIONAL POPULATION HEALTH REVIEW, Publisher: ELSEVIER SCIENCE INC, Pages: S513-S513, ISSN: 1098-3015

Conference paper

Osman T, Lew E, Lum EP-M, van Galen L, Dabas R, Sng BL, Car Jet al., 2020, PreAnaesThesia computerized health (PATCH) assessment: development and validation, BMC ANESTHESIOLOGY, Vol: 20, ISSN: 1471-2253

Journal article

Nazeha N, Pavagadhi D, Kyaw BM, Car J, Larrain GJ, Tudor Car Let al., 2020, Digitally competent health workforce: a scoping review of educational frameworks, Journal of Medical Internet Research, Vol: 22, Pages: 1-20, ISSN: 1438-8871

Background: Digital health technologies can be key to improving health outcomes, provided health workers are adequately trained to utilize these technologies. There have been efforts to identify digital competencies for different health worker groups, however, an overview of these efforts has yet to be consolidated and analysed.Objective: The objective of this review is to identify and study the existing digital health competency frameworks for health workers and provide recommendations for future digital health training initiatives and framework development.Methods: A literature search was performed to collate digital health competency frameworks published from year 2000. Six databases, including grey literature sources such as OpenGrey, ResearchGate, Google Scholar, Google, and websites of relevant associations were searched in November 2019. Screening and data extraction were performed in parallel by reviewers. The included evidence is narratively described in terms of characteristics, evolution, and structural composition of frameworks. A thematic analysis was also performed to identify common themes across the included frameworks. Findings: Thirty frameworks were included in this review, a majority of which aimed at nurses, originated from high-income countries, published since 2016 and developed via literature reviews, followed by expert consultations. The thematic analysis uncovered 28 digital health competency domains across the included frameworks. The most prevalent domains were pertaining to basic IT literacy, health information management, digital communication, ethical/legal/regulatory requirements, and data privacy/security. The HITCOMP framework was found to be the most comprehensive framework, as it presented 21 out of the 28 identified domains, had the highest number of competencies, and targeted a wide variety of health workers.Conclusions: Digital health training initiatives should focus on competencies relevant to a particular health worker grou

Journal article

Thach T-Q, Mahirah D, Sauter C, Roberts AC, Dunleavy G, Nazeha N, Rykov Y, Zhang Y, Christopoulos G, Soh C-K, Car Jet al., 2020, Associations of perceived indoor environmental quality with stress in the workplace, INDOOR AIR, Vol: 30, Pages: 1166-1177, ISSN: 0905-6947

Journal article

Xu X, Olsson M, Bajpai R, Aan MK, Yew YW, Wong S, Foong A, Thng S, Jarbrink K, Car Jet al., 2020, Concordance Between Physician-rated and Caregiver-perceived Disease Severity in Children with Atopic Dermatitis: A Cross-sectional Study, ACTA DERMATO-VENEREOLOGICA, Vol: 100, ISSN: 0001-5555

Journal article

Jimenez G, Spinazze P, Matchar D, Huat GKC, van der Kleij RMJJ, Chavannes NH, Car Jet al., 2020, Digital health competencies for primary healthcare professionals: A scoping review, INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, Vol: 143, ISSN: 1386-5056

Journal article

Su Y, Roberts AC, Yap HS, Car J, Kwok KW, Soh C-K, Christopoulos GIet al., 2020, White- and Blue- collar workers responses' towards underground workspaces, TUNNELLING AND UNDERGROUND SPACE TECHNOLOGY, Vol: 105, ISSN: 0886-7798

Journal article

Xu X, Griva K, Koh M, Lum E, Tan WS, Thng S, Car Jet al., 2020, Creating a Smartphone App for Caregivers of Children With Atopic Dermatitis With Caregivers, Health Care Professionals, and Digital Health Experts: Participatory Co-Design, JMIR MHEALTH AND UHEALTH, Vol: 8, ISSN: 2291-5222

Journal article

Car J, Koh GC-H, Foong PS, Wang CJet al., 2020, Video consultations in primary and specialist care during the covid-19 pandemic and beyond, BMJ-BRITISH MEDICAL JOURNAL, Vol: 371, ISSN: 0959-535X

Journal article

Murray CJL, Abbafati C, Abbas KM, Abbasi M, Abbasi-Kangevari M, Abd-Allah F, Abdollahi M, Abedi P, Abedi A, Abolhassani H, Aboyans V, Abreu LG, Abrigo MRM, Abu-Gharbieh E, Abu Haimed AK, Abushouk AI, Acebedo A, Ackerman IN, Adabi M, Adamu AA, Adebayo OM, Adelson JD, Adetokunboh OO, Afarideh M, Afshin A, Agarwal G, Agrawal A, Ahmad T, Ahmadi K, Ahmadi M, Ahmed MB, Aji B, Akinyemiju T, Akombi B, Alahdab F, Alam K, Alanezi FM, Alanzi TM, Albertson SB, Alemu BW, Alemu YM, Alhabib KF, Ali M, Ali S, Alicandro G, Alipour V, Alizade H, Aljunid SM, Alla F, Allebeck P, Almadi MAH, Almasi-Hashiani A, Al-Mekhlafi HM, Almulhim AM, Alonso J, Al-Raddadi RM, Altirkawi KA, Alvis-Guzman N, Amare B, Amare AT, Amini S, Amit AML, Amugsi DA, Anbesu EW, Ancuceanu R, Anderlini D, Anderson JA, Andrei T, Andrei CL, Anjomshoa M, Ansari F, Ansari-Moghaddam A, Antonio CAT, Antony CM, Anvari D, Appiah SCY, Arabloo J, Arab-Zozani M, Aravkin AY, Arba AAK, Aripov T, Ärnlöv J, Arowosegbe OO, Asaad M, Asadi-Aliabadi M, Asadi-Pooya AA, Ashbaugh C, Assmus M, Atout MMW, Ausloos M, Ausloos F, Ayala Quintanilla BP, Ayano G, Ayanore MA, Azari S, Azene ZN, B DB, Babaee E, Badawi A, Badiye AD, Bagherzadeh M, Bairwa M, Bakhtiari A, Bakkannavar SM, Balachandran A, Banach M, Banerjee SK, Banik PC, Baraki AG, Barker-Collo SL, Basaleem H, Basu S, Baune BT, Bayati M, Baye BA, Bedi N, Beghi E, Bell ML, Bensenor IM, Berhe K, Berman AE, Bhagavathula AS, Bhala N, Bhardwaj P, Bhattacharyya K, Bhattarai S, Bhutta ZA, Bijani A, Bikbov B, Biondi A, Bisignano C, Biswas RK, Bjørge T, Bohlouli S, Bohluli M, Bolla SRR, Boloor A, Bose D, Boufous S, Brady OJ, Braithwaite D, Brauer M, Breitborde NJK, Brenner H, Breusov AV, Briant PS, Briggs AM, Britton GB, Brugha T, Burugina Nagaraja S, Busse R, Butt ZA, Caetano dos Santos FL, Cámera LLAA, Campos-Nonato IR, Campuzano Rincon JC, Car J, Cárdenas R, Carreras G, Carrero JJ, Carvalho F, Castaldelli-Maia JM, Castelpietra G, Castro F, Catalá-López F, Causey K, Cederroth CR, Cercy KM Cet al., 2020, Five insights from the Global Burden of Disease Study 2019, The Lancet, Vol: 396, Pages: 1135-1159, ISSN: 0140-6736

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD 2019 incorporates data from 281 586 sources and provides more than 3·5 billion estimates of health outcome and health system measures of interest for global, national, and subnational policy dialogue. All GBD estimates are publicly available and adhere to the Guidelines on Accurate and Transparent Health Estimate Reporting. From this vast amount of information, five key insights that are important for health, social, and economic development strategies have been distilled. These insights are subject to the many limitations outlined in each of the component GBD capstone papers.

Journal article

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.

Request URL: http://wlsprd.imperial.ac.uk:80/respub/WEB-INF/jsp/search-html.jsp Request URI: /respub/WEB-INF/jsp/search-html.jsp Query String: id=00339836&limit=30&person=true&page=3&respub-action=search.html